The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

door: Design of Clinical Trials with the Desirability of Outcome Ranking Methodology

Statistical methods and related graphical representations for the Desirability of Outcome Ranking (DOOR) methodology. The DOOR is a paradigm for the design, analysis, interpretation of clinical trials and other research studies based on the patient centric benefit risk evaluation. The package provides functions for generating summary statistics from individual level/summary level datasets, conduct DOOR probability-based inference, and visualization of the results. For more details of DOOR methodology, see "Handbook of Generalized Pairwise Comparisons", Chapter 13 <doi:10.1201/9781003390855>. For more explanation of the statistical methods and the graphics, see the technical document and user manual of the DOOR 'Shiny' apps at <https://methods.bsc.gwu.edu>.

Version: 0.0.1
Depends: R (≥ 3.5)
Imports: dplyr, tidyr, ggplot2, forestplot, scales, methods, labeling
Suggests: testthat (≥ 3.0.0)
Published: 2025-06-28
DOI: 10.32614/CRAN.package.door
Author: Yijie He [aut, cre], Qihang Wu [ctb], Toshimitsu Hamasaki [ctb]
Maintainer: Yijie He <yih148 at gwu.edu>
License: GPL (≥ 3)
NeedsCompilation: no
CRAN checks: door results

Documentation:

Reference manual: door.pdf

Downloads:

Package source: door_0.0.1.tar.gz
Windows binaries: r-devel: door_0.0.1.zip, r-release: not available, r-oldrel: door_0.0.1.zip
macOS binaries: r-release (arm64): not available, r-oldrel (arm64): not available, r-release (x86_64): door_0.0.1.tgz, r-oldrel (x86_64): door_0.0.1.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=door to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.